Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes

Pediatric Diabetes

Volumn 18, Issue 5, 2017, Pages 340-347

  Keller, Marion ^a   Attia, Radhouène ^a   Beltrand, Jacques ^a,b   Djadi Prat, Juliette ^a   Nguyen Khoa, Thao ^a   Jay, Jean Philippe ^a,b   Cahané, Michel ^c   Choleau, Carine ^c   Robert, Jean Jacques ^a,b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Association l'Aide Aux Jeunes Diabétiques   (France)

Author keywords

children and adolescents; diabetes knowledge; insulin therapy; quality of life; type 1 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; PREMIXED INSULIN; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO ILLNESS; BOLUS INJECTION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PERCEPTION; POPULATION RISK; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; TREATMENT RESPONSE; TREND STUDY; ATTITUDE TO HEALTH; BLOOD; CHEMICALLY INDUCED; COMPLICATION; COST OF ILLNESS; DIABETIC COMPLICATION; FRANCE; HEALTH SURVEY; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; PATIENT EDUCATION; RISK;

ADOLESCENT; CHILD; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FRANCE; GLYCATED HEMOGLOBIN A; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; RISK;

EID: 84966460696     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12397     Document Type: Article

References (35)

1. The Diabetes Control and Complications Trial Research Group. Effect on intensive diabetes treatment of diabetes on the development and progression of long-term complications in adolescents with insulin dependent diabetes mellitus: Diabetes control and complications trial. J Pediatr 1994: 125: 177–188.
2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977–986.
3. Danne T, Bangstad H-J, Deeb L et al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2014: 15 (Suppl. 20): 115–134.
4. Siebenhofer A, Plank J, Berghold A et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006: 19: CD003287.
5. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009: 10: 52–58.
6. Lievre M, Marre M, Robert JJ et al. Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus. Diabetes Metab 2005: 31: 41–46.
7. Tubiana-Rufi N, Moret L, Czernichow P, Chwalow J, The Pediab Collaborative Group. Risk factors for poor glycemic control in diabetic children in France. Immigrant versus non-immigrant mothers. Diabetes Care 1995: 18: 1479–1482.
8. Mortensen HB, Hartling S, Petersen KE, the Danish Study Group of Diabetes in Childhood. A nationwide cross-sectional study of glycosylated haemoglobin in Danish children with type 1 diabetes. Diabet Med 1998: 5: 871–876.
9. Holl RW, Swift PG, Mortensen HB et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidoere Study Group. Eur J Pediatr 2003: 162: 22–29.
10. De Beaufort CE, Swift PG, Skinner CT et al. Continuing stability of centre differences in pediatric diabetes care: do advance diabetes treatment improve outcome? Diabetes Care 2007: 30: 2245–2250.
11. Paris CA, Imperatore G, Klingensmith G et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2009: 155: 183–189.
12. Rosilio M, Cotton JB, Wieliczko MC et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998: 21: 1146–1153.
13. Thompson SJ, Auslander WF, White NH. Comparison of single-mother and two-parent families on metabolic control of children with diabetes. Diabetes Care 2001: 24: 234–238.
14. Anderson BJ, Vangsness L, Connel A, Butler D, Goebel-Fabbri A, Laffel LM. Family conflict, adherence, and glycemic control in youth with short duration type 1 diabetes. Diabet Med 2002: 19: 635–642.
15. Moreland EC, Tovar A, Zuehelke JB, Butler DA, Milaszewski K, Laffel LM. The impact of physiological, therapeutic and psychosocial variables on glycemic control in youth with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1533–1544.
16. Urbach SL, LaFranchi S, Lambert L, Lapidus JA, Daneman D, Becker TM. Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2005: 6: 69–74.
17. Frey MA, Templin T, Ellis D, Gutai J, Podolski CL. Predicting metabolic control in the first 5 yr after diagnosis for youths with type 1 diabetes : the role of ethnicity and family structure. Pediatr Diabetes 2007: 8: 220–227.
18. Pihoker C, Badaru A, Anderson A et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth study. Diabetes Care 2013: 36: 27–33.
19. Butler DA, Zuehlke JB, Tovar A, Volkening LK, Anderson BJ, Laffel LM. The impact of modifiable family factors on glycemic control among youth with type 1 diabetes. Pediatr Diabetes 2008: 9: 373–381.
20. Redon I, Beltrand J, Martin D et al. Changes in insulin therapy regimens over 10 years in children and adolescents with type 1 diabetes attending diabetes camps. Pediatr Diabetes 2014: 15: 329–335.
21. Commission Pédagogique de l'AJD. Les Cahiers de l'AJD: Education au début du diabète de type 1. Les Editions de l'AJD, Paris, 2005–2009.
22. Martin D, Elie C, Godot C et al. Diabetes knowledge in adolescents with type 1 diabetes and their parents and glycemic control. Pediatr Diabetes 2016 Submitted.
23. Skinner TC, Hoey H, Skovlund SE, Hvidore Study Group on Childhood Diabetes. A short form of Diabetes Quality of life for Youth questionnaire: exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. Diabetologia 2006: 49: 621–628.
24. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2005.
25. Rewers MJ, Pillay K, de Beaufort C et al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2014: 15 (Suppl. 20): 102–114.
26. Swift PG, Skinner TC, de Beaufort CE et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group centre differences study 2005. Pediatr Diabetes 2010: 11: 271–278.
27. Phillip M, Battelino T, Rodriguez H et al. Use of insulin pump therapy in the pediatric age-group. Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007: 30: 1653–1662.
28. Wysocki T, Iannotti R, Weissberg-Benchell J et al. Diabetes problem solving by youths with type 1 diabetes and their caregivers: measurement, validation, and longitudinal associations with glycemic control. J Pediatr Psychol 2008: 33: 875–884.
29. Guttmann-Bauman I, Flaherty BP, Strugger M, McEvoy RC. Metabolic control and quality-of-life self-assessment in adolescents with IDDM. Diabetes Care 1998: 21: 915–918.
30. Hoey H, Aanstoot HJ, Chiarelli F et al. Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care 2002: 24: 1923–1928.
31. Dupasquier-Fediaevsky L, Tubiana-Rufi N, Collaborative Group PEDIAB. Factors associated with change in diabetes knowledge from childhood to adolescence. Diabetes Metab 2002: 28: 56–62.
32. Cameron FJ, Skinner TC, de Beaufort CE et al. Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med 2008: 25: 463–468.
33. Nardi L, Zucchini S, D'Alberton F et al. Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires. Pediatr Diabetes 2008: 9: 496–503.
34. Korey K, Claire M, Jennifer M, Dennis D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics 2009: 124: 1171–1179.
35. Ingerski L, Laffel L, Drotar D, Repaske D, Hood KK. Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes. Pediatr Diabetes 2010: 11: 563–571.